THE ROLE OF THE MONTREAL COGNITIVE ASSESSMENT (MOCA) IN SCREENING FOR VASCULAR DEMENTIA

Thị Tuyết Thanh Đinh, Trọng Hưng Nguyễn, Văn Thăng Chu

Main Article Content

Abstract

Objective: This study aimed to evaluate the role of the Montreal Cognitive Assessment (MoCA) in screening for vascular dementia .Methods: A cross-sectional descriptive study was conducted on 152 patients with cerebrovascular disease at the National Geriatric Hospital from October 2024 to July 2025. All participants underwent cognitive screening using the MoCA and were diagnosed with vascular dementia according to DSM-5 criteria. Results: The study included 152 patients with cerebrovascular disease, with a mean age of 73.41 ± 8.09 years. Among these, 21.7% were diagnosed with dementia, and 78.3% were non-demented. The mean MoCA score in the dementia group was 13.82 ± 1.86, significantly lower than that of the non-demented group (22.61 ± 3.40, p < 0.01). All cognitive domains assessed by MoCA including visuospatial/executive function, naming, attention, language, abstraction, memory, and orientation showed statistically significant differences between the two groups. Receiver Operating Characteristic (ROC) curve analysis demonstrated excellent discriminative ability of the MoCA, with an Area Under the Curve (AUC) of 0.994 (95% CI: 0.985–1.000, p < 0.001). The optimal cut-off score was determined to be 16/17, with a Youden Index of 0.944. At this threshold, MoCA achieved a sensitivity of 96.7%, specificity of 97.5%, positive predictive value of 91.4%, and negative predictive value of 99.1%. Conclusion: The MoCA is a highly sensitive and specific cognitive screening tool for the detection of vascular dementia

Article Details

References

Morgan AE, Mc Auley MT. Vascular dementia: From pathobiology to emerging perspectives. Ageing Research Reviews. 2024;96:102278. doi:10.1016/j.arr.2024.102278
2. Gannon OJ, Robison LS, Custozzo AJ, Zuloaga KL. Sex differences in risk factors for vascular contributions to cognitive impairment & dementia. Neurochem Int. 2019; 127:38-55. doi:10.1016/j.neuint.2018.11.014
3. Alphonce B, Meda J, Nyundo A. Incidence and predictors of post-stroke cognitive impairment among patients admitted with first stroke at tertiary hospitals in Dodoma, Tanzania: A prospective cohort study. PLOS ONE. 2024;19(4): e0287952. doi:10.1371/journal.pone. 0287952
4. Utomo NP, Pinzon RT. Risk factors of cognitive impairment post-ischemic stroke. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2023;59(1) :55. doi:10.1186/ s41983-023-00654-2
5. Guo X, Phan C, Batarseh S, Wei M, Dye J. Risk factors and predictive markers of post-stroke cognitive decline–A mini review. Front Aging Neurosci. 2024;16: 1359792. doi:10.3389/fnagi. 2024.1359792
6. Wei Q, Du B, Liu Y, et al. The Montreal cognitive assessment: normative data from a large, population-based sample of Chinese healthy adults and validation for detecting vascular cognitive impairment. Front Neurosci. 2024; 18: 1455129. doi:10.3389/fnins.2024. 1455129
7. Tu QY, Jin H, Ding BR, et al. Reliability, validity, and optimal cutoff score of the montreal cognitive assessment (changsha version) in ischemic cerebrovascular disease patients of hunan province, china. Dement Geriatr Cogn Dis Extra. 2013;3(1):25-36. doi:10.1159/000346845
8. Freitas S, Simões MR, Alves L, Vicente M, Santana I. Montreal Cognitive Assessment (MoCA): Validation Study for Vascular Dementia. Journal of the International Neuropsychological Society. 2012;18(6): 1031-1040. doi:10.1017/ S135561771200077X
9. Lan* NTX, Thắng** TC. Đánh giá thang MoCA trong tầm soát suy giảm nhận thức ở người Việt Nam. TCYHTPHCM. 2017;21(2):210-210.